Your browser doesn't support javascript.
loading
Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line.
Schmid, Benjamin; Prehn, Kennie R; Nimsanor, Natakarn; Garcia, Blanca Irene Aldana; Poulsen, Ulla; Jørring, Ida; Rasmussen, Mikkel A; Clausen, Christian; Mau-Holzmann, Ulrike A; Ramakrishna, Sarayu; Muddashetty, Ravi; Steeg, Rachel; Bruce, Kevin; Mackintosh, Peter; Ebneth, Andreas; Holst, Bjørn; Cabrera-Socorro, Alfredo.
Afiliação
  • Schmid B; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark. Electronic address: bsc@bioneer.dk.
  • Prehn KR; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark.
  • Nimsanor N; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark; Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand.
  • Garcia BIA; Neurometabolism Research Unit, Department of Drug Design and Pharmacology, University of Copenhagen, Denmark.
  • Poulsen U; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark.
  • Jørring I; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark.
  • Rasmussen MA; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark.
  • Clausen C; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark.
  • Mau-Holzmann UA; Institute of Medical Genetics and Applied Genomics, Division of Cytogenetics, Calwerstrasse 7, University of Tuebingen, 72076, Germany.
  • Ramakrishna S; Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Karnataka, India; University of Trans-Disciplinary Health Sciences & Technology (TDU), Bengaluru, Karnataka, India.
  • Muddashetty R; Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Karnataka, India.
  • Steeg R; Censo Biotechnologies, Edinburgh EH25 9PP, UK.
  • Bruce K; Censo Biotechnologies, Edinburgh EH25 9PP, UK.
  • Mackintosh P; Censo Biotechnologies, Edinburgh EH25 9PP, UK.
  • Ebneth A; Janssen Research & Development, Division of Janssen Pharmaceutica; N.V., Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Holst B; Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark.
  • Cabrera-Socorro A; Janssen Research & Development, Division of Janssen Pharmaceutica; N.V., Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium.
Stem Cell Res ; 34: 101349, 2019 01.
Article em En | MEDLINE | ID: mdl-30660866
ABSTRACT
Alzheimer's disease (AD) is the most frequent neurodegenerative disease amongst the elderly. The SNPs rs429358 and rs7412 in the APOE gene are the most common risk factor for sporadic AD, and there are three different alleles commonly referred to as APOE-ε2, APOE-ε3 and APOE-ε4. Induced pluripotent stem cells (iPSCs) hold great promise to model AD as such cells can be differentiated in vitro to the required cell type. Here we report the use of CRISPR/Cas9 technology employed on iPSCs from a healthy individual with an APOE-ε3/ε4 genotype to obtain isogenic APOE-ε2/ε2, APOE-ε3/ε3, APOE-ε4/ε4 lines as well as an APOE-knock-out line.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Técnicas de Cultura de Células / Técnicas de Inativação de Genes / Células-Tronco Pluripotentes Induzidas / Edição de Genes / Mutação Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Humans / Male Idioma: En Revista: Stem Cell Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Técnicas de Cultura de Células / Técnicas de Inativação de Genes / Células-Tronco Pluripotentes Induzidas / Edição de Genes / Mutação Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Humans / Male Idioma: En Revista: Stem Cell Res Ano de publicação: 2019 Tipo de documento: Article